CNS Pharmaceuticals, Inc. SEC filings CNSP
CNS Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 13, 2018. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Aug 25, 2026 | — |
| DEF 14A | Proxy statement | Aug 21, 2026 | Sep 30, 2026 |
| DEFA14A | Additional proxy material | Nov 12, 2025 | — |
| DEF 14A | Proxy statement | Oct 24, 2025 | Nov 17, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2025 | Nov 17, 2025 |
| DEF 14A | Proxy statement | Oct 28, 2024 | Nov 26, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 15, 2024 | Nov 26, 2024 |
| DEF 14A | Proxy statement | Apr 10, 2024 | Apr 30, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2024 | Apr 30, 2024 |
| DEF 14A | Proxy statement | Aug 14, 2023 | Sep 14, 2023 |
| DEF 14A | Proxy statement | Jul 7, 2022 | Jul 27, 2022 |
| PRE 14A | Preliminary proxy statement | Jun 27, 2022 | Jul 27, 2022 |
| DEF 14A | Proxy statement | Jun 8, 2021 | Jun 28, 2021 |
| PRE 14A | Preliminary proxy statement | May 27, 2021 | Jun 28, 2021 |
| DEF 14A | Proxy statement | Apr 24, 2020 | May 7, 2020 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1729427
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.